Biotech / Medical
GenVec - GNVC
An SI Board Since March 2010
Posts SubjectMarks Bans Symbol
98 9 0 GNVC
Emcee:  caly Type:  Moderated
GenVec, Inc. (NASDAQ: GNVC) is a biopharmaceutical company developing novel gene-based therapeutic drugs and vaccines.


Press Releases:

Google Finance News:

SEC Filings:

Shares Outstanding -

As of 10/31/2009, 106,335,723 shares
As of 10/31/2008, 88,422,96 shares

Stock Quote:
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
98Here's a link to the Presentation that's being made tomorrow: content.eGary Mohilner1Tuesday
97GenVec, Inc. (NASDAQ: GNVC), a clinical-stage gene delivery company, announced tSavant-January 11
96With less than 2.5 million shares outstanding, they've traded over 17 millioGary Mohilner-January 10
95Seems to be up to $10.44 today on high vol, retracing nowSavant-January 10
94This is certainly a sign that GNVC is alive with ideas, the question is, how wilGary Mohilner-January 5
93 GNVC jumped today on news to $4.47...retraced some GenVec Signs Option AgreemSavant-January 5
92Hopefully GNVC is now positioned to move dramatically on any positive news. I bGary Mohilner-12/1/2016
91GenVec, Inc. (NASDAQ: GNVC) ("GenVec" or "the Company") annoSavant-12/1/2016
90Thanks, I was aware this was happening, but unsure of the day and time of the prGary Mohilner-9/28/2016
89GAITHERSBURG, Md., Sept. 28, 2016 /PRNewswire/ -- GenVec, Inc. (NASDAQ: GNVC), aSavant-9/28/2016
88I believe we should get official word of a 6 months extension of the Nasdaq deadGary Mohilner-8/21/2016
87Get well soon. And yes, pneumonia is a v.serious condition. One doesn't immSavant-8/11/2016
86Savant, I had written the company in the hopes that they'd both hold a webcGary Mohilner-8/11/2016
85GAITHERSBURG, Md., Aug. 5, 2016 /PRNewswire/ -- GenVec, Inc. (NASDAQ: GNVC) todaSavant-8/5/2016
84 Y, takes fda a long time to boil water...hence, the reason I've named them.Savant-7/26/2016
83All those interested in the company knew the trial would resume, I'm uncertaGary Mohilner-7/26/2016
82 GM, a bit of positive news...Clinical resumed, after FDA review.. FDA Lifts ClSavant-7/26/2016
81Savant, I wrote the company regarding their failure to host a webcast to discusGary Mohilner15/14/2016
80GAITHERSBURG, Md., May 12, 2016 /PRNewswire/ -- GenVec, Inc. (NASDAQ: GNVC) Savant-5/13/2016
79I liked what was said at the quarterly webcast. It's quite clear that no saGary Mohilner-3/21/2016
78GAITHERSBURG, Md., March 9, 2016 /PRNewswire/ -- GenVec, Inc. (NASDAQ: GNVC)Savant-3/9/2016
77GAITHERSBURG, Md., March 2, 2016 /PRNewswire/ -- GenVec, Inc. (NASDAQ: GNVC)Savant-3/2/2016
76Update/ Highlights Ongoing Initiatives Involving the AdenoVerse(TM) Gene DeSavant-1/20/2016
75I suppose hearing clearly better describes what I'd hope for. It seems thatGary Mohilner-1/5/2016
74Gary, isn't that a bit much to ask, given the current state of humanity? &qSavant-1/3/2016
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
Copyright © 1995-2017 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.